COVALON TECHNOLOGIES LTD (COV.CA) Stock Price, Forecast & Analysis
TSX-V:COV • CA22282D3022
COV.CA Key Statistics, Chart & Performance
The current stock price of COV.CA is 1.9 CAD. In the past month the price increased by 13.1%. In the past year, price decreased by -26.92%.
COV.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to COV.CA. When comparing the yearly performance of all stocks, COV.CA is a bad performer in the overall market: 89.22% of all stocks are doing better.
COV.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to COV.CA. COV.CA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
COV.CA Financial Highlights
Over the last trailing twelve months COV.CA reported a non-GAAP Earnings per Share(EPS) of 0.03. The EPS decreased by -82.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.27% | ||
| ROA | 5.7% | ||
| ROE | 6.7% | ||
| Debt/Equity | 0.05 |
COV.CA Forecast & Estimates
9 analysts have analysed COV.CA and the average price target is 2.96 CAD. This implies a price increase of 55.68% is expected in the next year compared to the current price of 1.9.
For the next year, analysts expect an EPS growth of 76.57% and a revenue growth 6.67% for COV.CA
COV.CA Ownership
COV.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EPRX | EUPRAXIA PHARMACEUTICALS INC | N/A | 583.286M | ||
| EDT | SPECTRAL MEDICAL INC | N/A | 397.882M | ||
| HBP | HELIX BIOPHARMA CORP | N/A | 150.469M | ||
| MDNA | MEDICENNA THERAPEUTICS CORP | N/A | 79.24M | ||
| BCT | BRIACELL THERAPEUTICS CORP | N/A | 39.44M | ||
| MBX | MICROBIX BIOSYSTEMS INC | 5.94 | 33.252M | ||
| RVX | RESVERLOGIX CORP | N/A | 33.069M | ||
| HEM | HEMOSTEMIX INC | N/A | 17.573M | ||
| MPH | MEDICURE INC | N/A | 11.693M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About COV.CA
Company Profile
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm's solutions are designed for patients and made for care providers. The firm leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The firm has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.
Company Info
COVALON TECHNOLOGIES LTD
1660 Tech Avenue, Unit 5
Mississauga ONTARIO L4W 5S7 CA
CEO: Simon Smith
Employees: 41
Phone: 18777116055
COVALON TECHNOLOGIES LTD / COV.CA FAQ
Can you describe the business of COVALON TECHNOLOGIES LTD?
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm's solutions are designed for patients and made for care providers. The firm leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The firm has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.
What is the current price of COV stock?
The current stock price of COV.CA is 1.9 CAD. The price increased by 4.4% in the last trading session.
What is the dividend status of COVALON TECHNOLOGIES LTD?
COVALON TECHNOLOGIES LTD (COV.CA) has a dividend yield of 9.26%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of COV stock?
COV.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What do analysts say about COVALON TECHNOLOGIES LTD (COV.CA) stock?
9 analysts have analysed COV.CA and the average price target is 2.96 CAD. This implies a price increase of 55.68% is expected in the next year compared to the current price of 1.9.
What is COVALON TECHNOLOGIES LTD worth?
COVALON TECHNOLOGIES LTD (COV.CA) has a market capitalization of 52.48M CAD. This makes COV.CA a Micro Cap stock.
When does COVALON TECHNOLOGIES LTD (COV.CA) report earnings?
COVALON TECHNOLOGIES LTD (COV.CA) will report earnings on 2026-03-03.